Cyclophosphamide Injection, Powder, For Solution
Product Images NDC 70121-1238

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cyclophosphamide (NDC 70121-1238). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Cyclophosphamide For Injection Usp 1)

Chemical structure diagram of Cyclophosphamide, showing its molecular connectivity including a phosphoramide group, a piperazine ring, and a hydrate (H2O) component as part of the molecule.*

FDA Label Image

1 (Cyclophosphamide For Injection Usp 2)

Cyclophosphamide for Injection, USP 500 mg/vial label from Amneal Pharmaceuticals LLC. The label indicates the product is for intravenous infusion or direct injection use, cytotoxic agent, single-dose, sterile and non-pyrogenic. It includes storage instructions to keep the vial at or below 25°C and to refer to the USP controlled room temperature guidelines. The label also displays a barcode and manufacturing information.*

FDA Label Image

2 (Cyclophosphamide For Injection Usp 3)

The image shows the packaging label for Cyclophosphamide for Injection, USP, 500 mg per vial, by Amneal Pharmaceuticals LLC. It is a single-dose vial intended for intravenous infusion or direct injection. The label includes instructions for dilution with sterile water or 0.9% sodium chloride and storage requirements at or below 25°C (77°F). Cytotoxic agent warnings and manufacturing and distribution information are also visible.*

FDA Label Image

2 (Cyclophosphamide For Injection Usp 4)

Cyclophosphamide for Injection, USP 1 g/vial powder for solution by Amneal Pharmaceuticals LLC. The label indicates it is a sterile, non-pyrogenic cytotoxic agent intended for intravenous infusion or direct injection use. It is for single dose use and requires reconstitution with sterile water or sodium chloride injection. The label includes storage instructions and manufacturer details.*

FDA Label Image

1 (Cyclophosphamide For Injection Usp 5)

Cyclophosphamide for Injection, USP 1 g/vial powder for solution carton label by Amneal Pharmaceuticals LLC. Labeled for intravenous infusion or direct injection use as a cytotoxic agent that must be diluted. The label includes preparation instructions, storage conditions at or below 25°C, and notes it is a single-dose vial. Manufactured by Amneal Oncology Pvt. Ltd., India.*

FDA Label Image

1 (Cyclophosphamide For Injection Usp 6)

Label for Cyclophosphamide for Injection, USP 2 g/vial by Amneal Pharmaceuticals LLC. The label indicates this is a powder for solution for intravenous infusion or direct injection use. It is sterile, non-pyrogenic, cytotoxic, and intended for single dose use. Storage instructions specify storage at or below 25°C (77°F) with controlled room temperature conditions.*

FDA Label Image

1 (Cyclophosphamide For Injection Usp 7)

Label for Cyclophosphamide for Injection, USP 2 g/vial by Amneal Pharmaceuticals LLC. The label indicates that it is a cytotoxic agent for intravenous infusion or direct injection use and must be diluted. It includes instructions for use, storage conditions, and states it is a single-dose vial. Manufactured by Amneal Oncology Pvt. Ltd., India, and distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.